June 22, 2020 / 5:19 AM / 20 days ago

BRIEF-Basilea Pharmaceutica Receives CHF 5 Million Milestone Payment

June 22 (Reuters) - Basilea Pharmaceutica AG:

* BASILEA RECEIVES CHF 5 MILLION MILESTONE PAYMENT RELATED TO MARKETING AUTHORIZATION OF ANTIFUNGAL CRESEMBA® IN RUSSIA

* MILESTONE WAS TRIGGERED BY GRANTING OF MARKETING AUTHORIZATION FOR ANTIFUNGAL CRESEMBA(®) (ISAVUCONAZOLE) IN RUSSIAN FEDERATION.

* IS STILL ELIGIBLE FOR REGULATORY AND SALES MILESTONE PAYMENTS OF APPROXIMATELY USD 630 MILLION, IN ADDITION TO RECEIVING MID-TEEN ROYALTIES ON IN-MARKET SALES OF CRESEMBA Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below